Geron Expands Senior Leadership of Its Development Team
April 18, 2019 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team’s senior leadership with the addition of three highly...
Geron to Present at Needham Healthcare Conference
April 02, 2019 16:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a...
Geron Appoints Two New Independent Board Members
March 28, 2019 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointments of Dawn C. Bir and Elizabeth G. O’Farrell as independent members of its Board...
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 21, 2019 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 78,400 shares of...
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
March 07, 2019 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and full year ended December 31, 2018 and recent...
Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
February 28, 2019 16:30 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2018 financial results after the market...
Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer
January 31, 2019 16:20 ET
|
Geron Corporation
Aleksandra Rizo, M.D., Ph.D., former clinical lead for the imetelstat program at Janssen, joins Geron as Chief Medical OfficerAdditional office to be opened in New Jersey to support expansion of...
Geron Appoints Vice President, Pharmacovigilance and Drug Safety
January 17, 2019 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the hiring of the first of several key leadership positions as it rebuilds the in-house...
Geron Announces New Board Leadership Structure
December 31, 2018 07:30 ET
|
Geron Corporation
CEO John A. Scarlett Appointed Chairman Karin Eastham Appointed Lead Independent Director MENLO PARK, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced...
Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy
December 03, 2018 16:22 ET
|
Geron Corporation
Data Reporting Median Overall Survival of 29.9 Months in High-Dose Arm Presented at the 60th American Society of Hematology Annual Meeting MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) --...